Convergence in oncology summit

September 12-13 2019
Biopôle Lausanne, Switzerland

About

The Convergence in Oncology Summit is an international annual assembly of industry leaders, entrepreneurs, and investors active in the field of Oncology to debate and explore synergies that can accelerate the development of the most promising solutions in the field.

From diagnostics to therapeutics, rapid change in technology innovation modifies the landscape faster than any organizations can keep up with. Convergence of technologies from mature and emerging sectors are creating new opportunities that can significantly accelerate disruptive solutions that benefit patients globally.

The principal aim of this Summit is to promote development of new solutions through convergence and sharing of opportunities in the field of Oncology. The Summit is organized by professionals for professionals and we look forward to welcoming you to Lausanne, Switzerland, for networking and sharing of knowledge among industry leaders, entrepreneurs, academics and investors.

Session Highlights

This year’s Summit will focus on Prevention & Diagnostics, Therapy, and Digitization, with many opportunities to network and explore synergies.

The Summit is organized in several consecutive sessions led by a panel of industry leaders bringing their perspective to the topic, followed by several presentations by leading company CEOs covering innovative emerging and disrupting solutions relevant to the panel discussion.

Who should attend?

The annual event is attended by CEOs, entrepreneurs, investors, and thought leaders from both academia and industry to discuss and debate the key issues of global concern in Oncology.

Provisional Schedule 2019

The Summit is organized around seven consecutive plenary panel sessions over two days.

11:00>12:45
Registration and Welcome Lunch
12:45>13:30
Official Opening
13:30 > 15:00
Advances in Immune Oncology
15:45>17:15
Emerging Nuclear Medicines: A New Era for Targeted Therapy
18:00>19:30
Advances in Molecular Diagnostics: Early Cancer Detection & Therapy Optimization
19:45-20:15
Salus Excellence Award
20:30>22:30
Cocktail Dinner
08:00>08:30
Welcome coffee
08:30>10:00
Innovations in Medical Devices for Cancer Therapy
10:30>12:00
Mastering Signal to Noise: Machine Learning & Artificial Intelligence in Oncology
13:15>14:45
Opportunities for Accelerating Regulatory Approval of Novel Solutions in Oncology
15:15>16:30
Health Economics: Creating Awareness for Prevention and Holistic Therapy; Implications for Patients and Society

 Industry Leaders     Entrepreneurs     Investors
• Panel discussions • Company presentations  • Investment outlook
Digitization    Prevention    Diagnostics    Therapeutics

Speakers 2018

Patrick
Amstutz
Christina
Busmalis
Jurgi
Camblong
Raphael
Conz
Erik 
de Heus
Antoine
De Weck
Nicolas
Demierre
Sorin
Draghici
Tania
Dussey-Cavassini
Brian
Hashemi
Lana
Kandalaft
Catherine
Labouchère
Nicolas
Mach
Chris
Martin
Olivier
Michielin
Nasri
Nahas
Vincent
Ossipow
Vaclav
Potesil
Venkat
Reddy
Heinrich
Röder
Christopher
Rudolf
Diana
Saraceni
Marc
Sluijs
Cristina
Stefan
Hiroaki
Tanaka
Thierry
Weber
Karen
Zinkewich-Peotti

PARTICIPATING COMPANIES 2018

Location

Aquatis Conference Center @Biopôle Lausanne
Route de Berne 148
1010 Lausanne
Switzerland

Venue

Aquatis is located at Biopôle Lausanne, one-hour journey from Geneva Airport and 15 minutes from Lausanne train station. It hosts a Conference Center, a Hotel, and the largest freshwater aquarium-vivarium in Europe. The superior business hotel houses a magnificent modern conference centre, restaurants, and a terrace, located in Lausanne-Vennes, just off the A9 motorway. The hotel has straight access to the M2 metro station at Vennes, with direct connections to Lausanne city centre and the lakeside area of Lac Leman.

Accomodation

A limited number of hotel rooms are available at the Conference Hotel Aquatis. Program attendees, speakers and guests may benefit for the special rate of CHF 150.00 single room or CHF 170.00 double room, breakfast included.

Book now

«When talking about Oncology, time is of essence and shortening. The only option we have left today is to converge and work together to speed up oncology research.» Nasri Nahas, CEO Biopôle

Organizers & Sponsors

Biopôle Lausanne is home of Life Sciences innovations in Switzerland. Biopôle hosts a vibrant community where industry and academia share a world-class combination of infrastructure, added value services, living space. Today, it houses more than 75 companies and clinical development teams, a startup incubator and 25 world-famous research groups. Biopôle SA is the owner of the site on which the Biopôle Lausanne life science campus is situated. Biopôle SA makes sure to insure the proper development of the site, to promote the site as a major place to be in the life sciences in Europe and to manage a lively community.

Salus Partners SA is a Swiss asset management firm based in Lausanne, Switzerland. The company has a special expertise in proven health technologies and seeks to generate exceptional returns while bringing good outcomes to society.

Keep me posted

Subscribe our contact list to receive updates about the Convergence in Oncology Summit 2018.